{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:41:28Z","timestamp":1760298088105},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2008.12.026","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T09:02:18Z","timestamp":1243501338000},"page":"A24-A29","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S1","title":["Anal HPV genotypes and related displasic lesions in Italian and foreign born high-risk males"],"prefix":"10.1016","volume":"27","author":[{"given":"Giovanna","family":"Orlando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosangela","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Michela","family":"Fasolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Amendola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliano","family":"Rizzardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Tanzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2008.12.026_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.qai.0000159669.80207.12","article-title":"A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic","volume":"40","author":"Chiao","year":"2005","journal-title":"J Acquir Immun Defic Syndr"},{"key":"10.1016\/j.vaccine.2008.12.026_bib2","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/00126334-200412150-00004","article-title":"HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?","volume":"37","author":"Bower","year":"2004","journal-title":"J Acquir Immun Defic Syndr"},{"key":"10.1016\/j.vaccine.2008.12.026_bib3","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1086\/368220","article-title":"Human papillomavirus infection in men attending a sexually transmitted disease clinic","volume":"187","author":"Baldwin","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.12.026_bib4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/507432","article-title":"Prevalence of HPV infection among men: a systematic review of the literature","volume":"194","author":"Dunne","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.12.026_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.qco.0000199019.50451.a8","article-title":"Human papillomavirus and anal intraepithelial neoplasia","volume":"19","author":"Fox","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.12.026_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973\u20132000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2008.12.026_bib7","unstructured":"MMWR Quadrivalent Human Papillomavirus Vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2007;56 (RR02):1\u201324."},{"key":"10.1016\/j.vaccine.2008.12.026_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","article-title":"Natural history of anogenital human papillomavirus infection and neoplasia","volume":"31","author":"Schiffman","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.vaccine.2008.12.026_bib9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus type associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.12.026_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.12.026_bib11","first-page":"S1\/4","article-title":"The epidemiology of genital human papillomavirus infection","volume":"24S1","author":"Trottie","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.026_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.12.026_bib13","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.12.026_bib14","first-page":"209","article-title":"The use of polymerase chain reaction amplifications for the detection of genital human papillomaviruses","volume":"7","author":"Manos","year":"1989","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.026_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000333842","article-title":"Polymerase chain reaction amplification of human papillomavirus DNA from archival. Papanicolaou-stained cervical smears","volume":"40","author":"Puranen","year":"1996","journal-title":"Acta Cytol."},{"key":"10.1016\/j.vaccine.2008.12.026_bib16","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/infdis\/170.5.1077","article-title":"Identification and assessment of know and novel human papillomavirus by polymarase chain reaction amplification, restriction fragment legth polymorphisms, nucleotide sequence, and phylogenetic algorithms","volume":"170","author":"Bernad","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.12.026_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/0003-4819-138-6-200303180-00008","article-title":"High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse","volume":"138","author":"Piketty","year":"2003","journal-title":"Ann Int Med"},{"key":"10.1016\/j.vaccine.2008.12.026_bib18","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1086\/424599","article-title":"Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy","volume":"190","author":"Wilkin","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.026_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsagu\u00e9","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"6C","key":"10.1016\/j.vaccine.2008.12.026_bib20","first-page":"4473","article-title":"Human papillomavirus (HPV). DNA aberrations and cell cycle progression in anal squamous cell carcinoma patients","volume":"27","author":"Laytragoon-Lewin","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1016\/j.vaccine.2008.12.026_bib21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9343(00)00349-1","article-title":"Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men","volume":"108","author":"Goldie","year":"2000","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.026_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/OLQ.0b013e31815aba8c","article-title":"Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic","volume":"35","author":"Scott","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2008.12.026_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/QAI.0b013e318156ec7b","article-title":"Human papillomavirus genotypes and anal-related lesions among HIV-1\u2014infected men in Milan, Italy","volume":"47","author":"Orlando","year":"2008","journal-title":"JAIDS"},{"key":"10.1016\/j.vaccine.2008.12.026_bib24","first-page":"343","article-title":"Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students","volume":"11","author":"Xi","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2008.12.026_bib25","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1099\/0022-1317-81-12-2959","article-title":"Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia","volume":"81","author":"Villa","year":"2000","journal-title":"J Gen Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.12.026_bib26","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/jmv.21002","article-title":"Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal","volume":"79","author":"Pista","year":"2007","journal-title":"J Med Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.12.026_bib27","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/ijc.22481","article-title":"High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18","volume":"120","author":"Sichero","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2008.12.026_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/420787","article-title":"Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women","volume":"190","author":"Aho","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.12.026_bib29","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/jnci\/94.16.1249","article-title":"Association of human papillomavirus type 58 variant with the risk of cervical cancer","volume":"94","author":"Chan","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.026_bib30","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1128\/JCM.01785-07","article-title":"Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer","volume":"46","author":"Cheung","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.026_bib31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08017544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08017544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T08:57:25Z","timestamp":1545209845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08017544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":31,"alternative-id":["S0264410X08017544"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.12.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}